Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Schizophrenia Research|October 7, 2016
Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophreniaSteven D Targum, Robert Risinger, Yangchun Du, et al.
Frontiers in Psychiatry|August 4, 2025
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorderSteven D Targum, Aksu Gunay, Alex Leow, et al.
Molecular Psychiatry|December 31, 2021
A novel peripheral biomarker for depression and antidepressant responseSteven D Targum, Jeffrey Schappi, Athanasia Koutsouris, et al.
Journal of Psychiatric Research|April 9, 2013
A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive DisorderSteven D Targum, Pamela C Wedel, Jill Robinson, et al.
Schizophrenia Research|September 11, 2024
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trialsWilliam P Horan, Steven D Targum, Amy Claxton, et al.
Journal of Psychiatric Research|September 25, 2012
An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discoveryMaurizio Fava, Steven D Targum, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|July 7, 2017
Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus MeetingPhillip B Chappell, Michelle Stewart, Larry Alphs, et al.
Journal of Clinical Psychopharmacology|March 19, 2026
Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant DepressionAristide Merola, Yuki Mukai, Tjerk Bueters, et al.
Journal of Clinical Psychopharmacology|June 27, 2003
A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorderDouglas E Feltner, Jerri G Crockatt, Steven J Dubovsky, et al.
Schizophrenia Research|March 13, 2026
Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophreniaSteven D Targum, Carolyn Watson, Amy Claxton, et al.
Pageof 6